Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.
Nasdaq Tumbles 1.5%; BBQ Holdings Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 1.5% on Tuesday.
Why U.S. Stocks Are Trading Mixed; Labor Costs Increase Higher-Than-Expected In Q2
U.S. stocks traded mixed this morning, with the Nasdaq dropping around 90 points on Tuesday.
Cowen & Co. Downgrades Quanterix to Market Perform, Lowers Price Target to $18
Cowen & Co. analyst Max Masucci downgrades Quanterix (NASDAQ:QTRX) from Outperform to Market Perform and lowers the price target from $38 to $18.
Goldman Sachs Maintains Neutral on Quanterix, Lowers Price Target to $30
Goldman Sachs maintains Quanterix (NASDAQ:QTRX) with a Neutral and lowers the price target from $35 to $30.
SVB Leerink Maintains Outperform on Quanterix, Lowers Price Target to $35
SVB Leerink analyst Puneet Souda maintains Quanterix (NASDAQ:QTRX) with a Outperform and lowers the price target from $50 to $35.
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell
• The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.